Clinical Trial Update: Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients [NA]

View source ↗

Summary

A clinical trial evaluating strategies to prevent cardiac allograft vasculopathy in heart transplant recipients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Vasculopathy

Snippet

Sponsor: University of Minnesota | Conditions: Cardiac Allograft Vasculopathy | NA | Status: WITHDRAWN